International Journal of Radiation Biology,
Год журнала:
2024,
Номер
100(4), С. 505 - 526
Опубликована: Янв. 5, 2024
Purpose
The
discovery
of
X-rays
was
followed
by
a
variety
attempts
to
treat
infectious
diseases
and
various
other
non-cancer
with
ionizing
radiation,
in
addition
cancer.
There
has
been
recent
resurgence
interest
the
use
such
radiotherapy
for
diseases.
Non-cancer
which
currently
proposed
include
refractory
ventricular
tachycardia,
neurodegenerative
(e.g.
Alzheimer's
disease
dementia),
Coronavirus
Disease
2019
(COVID-19)
pneumonia,
all
ongoing
clinical
studies
that
deliver
radiation
doses
0.5–25
Gy
single
fraction
or
multiple
daily
fractions.
In
effects,
historical
indications
predominantly
used
some
countries
Germany)
osteoarthritis
degenerative
bones
joints.
This
narrative
review
gives
an
overview
biological
rationale
preclinical
diseases,
discusses
plausibility
rationale,
considers
long-term
risks
cancer
Nature,
Год журнала:
2022,
Номер
615(7950), С. 134 - 142
Опубликована: Дек. 5, 2022
Abstract
Preventing
SARS-CoV-2
infection
by
modulating
viral
host
receptors,
such
as
angiotensin-converting
enzyme
2
(ACE2)
1
,
could
represent
a
new
chemoprophylactic
approach
for
COVID-19
that
complements
vaccination
2,3
.
However,
the
mechanisms
control
expression
of
ACE2
remain
unclear.
Here
we
show
farnesoid
X
receptor
(FXR)
is
direct
regulator
transcription
in
several
tissues
affected
COVID-19,
including
gastrointestinal
and
respiratory
systems.
We
then
use
over-the-counter
compound
z-guggulsterone
off-patent
drug
ursodeoxycholic
acid
(UDCA)
to
reduce
FXR
signalling
downregulate
human
lung,
cholangiocyte
intestinal
organoids
corresponding
mice
hamsters.
UDCA-mediated
downregulation
reduces
susceptibility
vitro,
vivo
lungs
livers
perfused
ex
situ.
Furthermore,
reveal
UDCA
nasal
epithelium
humans.
Finally,
identify
correlation
between
treatment
positive
clinical
outcomes
after
using
retrospective
registry
data,
confirm
these
findings
an
independent
validation
cohort
recipients
liver
transplants.
In
conclusion,
has
role
controlling
provide
evidence
modulation
this
pathway
be
beneficial
reducing
infection,
paving
way
future
trials.
Nature Cell Biology,
Год журнала:
2023,
Номер
25(4), С. 550 - 564
Опубликована: Март 9, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
RNA
virus
responsible
for
disease
2019
(COVID-19)
pandemic.
Although
SARS-CoV-2
was
reported
to
alter
several
cellular
pathways,
its
impact
on
DNA
integrity
and
mechanisms
involved
remain
unknown.
Here
we
show
that
causes
damage
elicits
an
altered
response.
Mechanistically,
proteins
ORF6
NSP13
cause
degradation
of
response
kinase
CHK1
through
proteasome
autophagy,
respectively.
loss
leads
deoxynucleoside
triphosphate
(dNTP)
shortage,
causing
impaired
S-phase
progression,
damage,
pro-inflammatory
pathways
activation
senescence.
Supplementation
deoxynucleosides
reduces
that.
Furthermore,
N-protein
impairs
53BP1
focal
recruitment
by
interfering
with
damage-induced
long
non-coding
RNAs,
thus
reducing
repair.
Key
observations
are
recapitulated
in
SARS-CoV-2-infected
mice
patients
COVID-19.
We
propose
SARS-CoV-2,
boosting
ribonucleoside
levels
promote
replication
at
expense
dNTPs
hijacking
RNAs'
biology,
threatens
genome
activation,
induction
inflammation
Cellular and Molecular Immunology,
Год журнала:
2023,
Номер
21(2), С. 171 - 183
Опубликована: Ноя. 20, 2023
Abstract
An
ancient
conflict
between
hosts
and
pathogens
has
driven
the
innate
adaptive
arms
of
immunity.
Knowledge
about
this
interplay
can
not
only
help
us
identify
biological
mechanisms
but
also
reveal
pathogen
vulnerabilities
that
be
leveraged
therapeutically.
The
humoral
response
to
SARS-CoV-2
infection
been
focus
intense
research,
role
immune
system
received
significantly
less
attention.
Here,
we
review
current
knowledge
various
means
employs
evade
defense
systems.
We
consider
immunity
in
vaccines
phenomenon
long
COVID.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Авг. 19, 2023
Abstract
Geroscience
is
becoming
a
major
hope
for
preventing
age-related
diseases
and
loss
of
function
by
targeting
biological
mechanisms
aging.
This
unprecedented
paradigm
shift
requires
optimizing
the
design
future
clinical
studies
related
to
aging
in
humans.
Researchers
will
face
number
challenges,
including
ideal
populations
study,
which
lifestyle
Gerotherapeutic
interventions
test
initially,
selecting
key
primary
secondary
outcomes
such
trials,
biomarkers
are
most
valuable
both
predicting
or
monitoring
responses
(“Gerodiagnostics”).
article
reports
main
results
Task
Force
experts
Geroscience.
The Journal of Experimental Medicine,
Год журнала:
2024,
Номер
221(4)
Опубликована: Фев. 22, 2024
Cellular
senescence
is
a
critical
stress
response
program
implicated
in
embryonic
development,
wound
healing,
aging,
and
immunity,
it
backs
up
apoptosis
as
an
ultimate
cell-cycle
exit
mechanism.
In
analogy
to
replicative
exhaustion
of
telomere-eroded
cells,
premature
types
senescence—referring
oncogene-,
therapy-,
or
virus-induced
senescence—are
widely
considered
irreversible
growth
arrest
states
well.
We
discuss
here
that
entry
into
full-featured
not
necessarily
permanent
endpoint,
but
dependent
on
essential
maintenance
components,
potentially
transient.
Unlike
binary
state
switch,
we
view
with
its
extensive
epigenomic
reorganization,
profound
cytomorphological
remodeling,
distinctive
metabolic
rewiring
rather
journey
toward
condition
variable
strength
depth.
Senescence-underlying
maintenance-essential
molecular
mechanisms
may
allow
reentry
if
continuously
provided.
Importantly,
senescent
cells
resumed
proliferation
fundamentally
differ
from
those
never
entered
senescence,
hence
would
reflect
reversion
dynamic
progression
post-senescent
comes
distinct
functional
clinically
relevant
ramifications.
Physiological Reviews,
Год журнала:
2022,
Номер
103(1), С. 609 - 647
Опубликована: Сен. 1, 2022
Cardiovascular
diseases
(CVDs)
constitute
the
prime
cause
of
global
mortality,
with
an
immense
impact
on
patient
quality
life
and
disability.
Clinical
evidence
has
revealed
a
strong
connection
between
cellular
senescence
worse
cardiac
outcomes
in
majority
CVDs
concerning
both
ischemic
nonischemic
cardiomyopathies.
Cellular
is
characterized
by
cell
cycle
arrest
accompanied
alterations
several
metabolic
pathways,
resulting
morphological
functional
changes.
Metabolic
rewiring
senescent
cells
results
marked
paracrine
activity,
through
unique
secretome,
often
exerting
deleterious
effects
neighboring
cells.
Here,
we
recapitulate
hallmarks
key
molecular
pathways
involved
context
summarize
different
roles
CVDs.
In
last
few
years,
possibility
eliminating
various
pathological
conditions
been
increasingly
explored,
giving
rise
to
field
senotherapeutics.
Therefore,
additionally
attempt
clarify
current
state
this
focus
discuss
potential
implementing
senolytics
as
treatment
option
heart
disease.
European Respiratory Journal,
Год журнала:
2022,
Номер
60(6), С. 2102725 - 2102725
Опубликована: Июнь 21, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
utilises
the
angiotensin-converting
enzyme
(ACE2)
transmembrane
peptidase
as
cellular
entry
receptor.
However,
whether
SARS-CoV-2
in
alveolar
compartment
is
strictly
ACE2-dependent
and
to
what
extent
virus-induced
tissue
damage
and/or
direct
immune
activation
determines
early
pathogenesis
still
elusive.Spectral
microscopy,
single-cell/-nucleus
RNA
sequencing
or
ACE2
"gain-of-function"
experiments
were
applied
infected
human
lung
explants
adult
stem
cell
derived
organoids
correlate
related
host
factors
with
tropism,
propagation,
virulence
compared
SARS-CoV,
influenza
Middle
East
(MERS-CoV).
Coronavirus
disease
2019
(COVID-19)
autopsy
material
was
used
validate
ex
vivo
results.We
provide
evidence
that
expression
must
be
considered
scarce,
thereby
limiting
propagation
alveolus.
Instead,
lungs
COVID-19
samples
showed
macrophages
frequently
positive
for
SARS-CoV-2.
Single-cell/-nucleus
transcriptomics
further
revealed
nonproductive
virus
uptake
a
inflammatory
anti-viral
activation,
especially
"inflammatory
macrophages",
comparable
those
induced
by
SARS-CoV
MERS-CoV,
but
different
from
NL63
infection.Collectively,
our
findings
indicate
severe
injury
probably
results
macrophage-triggered
rather
than
viral
of
compartment.
Nature Aging,
Год журнала:
2023,
Номер
3(7), С. 829 - 845
Опубликована: Июль 6, 2023
Abstract
Older
age
is
one
of
the
strongest
risk
factors
for
severe
COVID-19.
In
this
study,
we
determined
whether
age-associated
cellular
senescence
contributes
to
severity
experimental
Aged
golden
hamsters
accumulate
senescent
cells
in
lungs,
and
senolytic
drug
ABT-263,
a
BCL-2
inhibitor,
depletes
these
at
baseline
during
SARS-CoV-2
infection.
Relative
young
hamsters,
aged
had
greater
viral
load
acute
phase
infection
displayed
higher
levels
sequelae
post-acute
phase.
Early
treatment
with
ABT-263
lowered
pulmonary
(but
not
young)
animals,
an
effect
associated
lower
expression
ACE2,
receptor
SARS-CoV-2.
also
led
systemic
senescence-associated
secretory
phenotype
amelioration
early
late
lung
disease.
These
data
demonstrate
causative
role
pre-existing
on
COVID-19
have
clear
clinical
relevance.